Showing 6661-6670 of 23150 results for "".
When Disaster Strikes: Challenges in Securing Funds for Disaster Medicine
https://reachmd.com/programs/the-pulse-of-emergency-medicine/when-disaster-strikes-challenges-securing-funds-disaster-medicine/8044/talks about challenges of securing funding for disaster relief in emergency medicine, and the integration of citizen volunteers in disaster incidents.The Real Doctor Will See You Shortly: A Physician's First Year
https://reachmd.com/programs/book-club/real-doctor-will-see-you-now-physicians-first-year/7874/In medical school, Matt McCarthy dreamed of being a different kind of doctor—the sort of mythical, unflappable physician who could reach unreachable patients. But when a new admission to the critical care unit almost died his first night on call, he found himself scrambling. Visions of mastery quickFlibanserin 101: Benefits vs Risks for Women with Hypoactive Sexual Desire Disorder
https://reachmd.com/programs/sexmed/flibanserin-101-benefits-risks-women-hypoactive-sexual-desire-disorder/7679/Flibanserin's approval by the FDA for women with hypoactive sexual desire disorder (HSDD), touted by the press as the "Pink Viagra," created an enormous amount of media hype across the nation. But the facts on this drug's mechanism of action, intended benefits, adverse effects, and efficacy borne inTransgender Health: Sex, Gender Identity, and Gender Expression
https://reachmd.com/programs/clinicians-roundtable/transgender-health-sex-gender-identity-and-gender-expression/7044/What does transgender mean? What are common health issues found in transgender patients? Host Dr. Prathima Setty welcomes Dr. Draion M. Burch, also known as "Dr Drai". Dr. Drai will address these questions, as well as, information on screening, hormone therapy, and resources available for cliniciansMedical Considerations in the Oral Health of Long-Term Care Patients
https://reachmd.com/programs/advances-in-long-term-care-medicine/medical-considerations-in-the-oral-health-of-long-term-care-patients/6016/A patient's mouth can literally serve as a window to their overall health. Systemic conditions that are common among many older patients, such as diabetes, often have oral manifestations. What are some of the symptoms to look for, and how can we promote and preserve the oral health of vulnerable patGenetic Clues to Heart Health
https://reachmd.com/programs/heart-matters/genetic-clues-to-heart-health/5929/We know that genes play a role in cardiovascular health, but new research has identified specific DNA regions that are associated with risk factors for coronary heart disease. It's estimated that 30-50% of cardiovascular health is influenced by family history or genetics, while the rest is influenceThe Hypertension Paradox: Better Treatment, Worse Outcomes
https://reachmd.com/programs/heart-matters/the-hypertension-paradox-better-treatment-worse-outcomes/4922/In recent years, we have developed a sufficient understanding of the mechanisms behind hypertension that has led to the evolution of numerous diagnostic and treatment options. Yet the prevalence of hypertension persists. Why does hypertension continue to disable and kill millions throughout the worlSoccer Injuries and How to Treat Them
https://reachmd.com/programs/focus-on-sports-medicine/soccer-injuries-and-how-to-treat-them/3670/The sports hernia is one of the most difficult injuries to diagnose and treat in elite soccer players. Join host Dr. Sherwin Ho as he talks with Dr. Riley Williams, associate professor of orthopedic surgery at Weill Medical College and medical director for the New York Red Bulls professional soccerRaltegravir Therapy for Multi-Drug Resistant HIV
https://reachmd.com/programs/clinicians-roundtable/raltegravir-therapy-for-multi-drug-resistant-hiv/3521/In the quest to find therapies for multi-drug resistant HIV, researchers have zeroed in on raltegravir. The latest data indicates this potent agent provides the highest reported virologic suppression rate among multi-drug resistant patients. Is raltegravir proving more effective than antiretroviralsReducing Proteinuria and Function Loss in IgAN: A Recap of the NefigArd Trial
https://reachmd.com/programs/frontlines-iga-nephropathy/reducing-proteinuria-and-function-loss-in-igan-a-recap-of-the-nefigard-trial/26940/Dive into a study focused on how the treatment option Nefecon may be able to reduce proteinuria and protect kidney function in IgAN patients.